Mr. Robert Jackson is President, Global Innovative Product Development Group at Glenmark Pharmaceuticals Ltd. He leads global product development in the innovative and specialty portfolio at Glenmark. Prior to joining Glenmark in 2015, Mr. Jackson amassed more than 30 years of experience in pharmaceutical research and development including leadership roles in global manufacturing, regulatory affairs, technical research and development, quality assurance, quality control & corporate project management, and pre- & post-approval drug development for more than a dozen approved products in a variety of therapeutic areas at companies like Forest Laboratories, Inc. and Novartis. Mr. Robert Jackson is President, Global Innovative Product Development Group at Glenmark Pharmaceuticals Ltd. He leads global product development in the innovative and specialty portfolio at Glenmark. Prior to joining Glenmark in 2015, Mr. Jackson amassed more than 30 years of experience in pharmaceutical research and development including leadership roles in global manufacturing, regulatory affairs, technical research and development, quality assurance, quality control & corporate project management, and pre- & post-approval drug development for more than a dozen approved products in a variety of therapeutic areas at companies like Forest Laboratories, Inc. and Novartis.

Intrested in research and development.